Page 2 of Pfizer

USFDA, drug approvals, Pfizer, RSV, RSV in infants, healthcare news, pharma news,

USFDA approves Pfizer’s vaccine for mothers to prevent RSV in infants

Moreover, the USFDA has asked the company to conduct postmarketing studies to assess the signal of serious risk of preterm…

August 22, 2023 14:10 IST

Glenmark, Glenmark pharmaceuticals, diabetes, blood sugar, healthcare news, pharma news,

Pharma major Pfizer asks doctors to stop using these life-saving antibiotics; Here’s why

Pfizer was warned against the following drugs: Magnex, Zosyn, Magnamycin injections and Magnex Forte.

May 18, 2023 15:23 IST

Pfizer, covid, covid 19 booster, covid news, healthcare news, pharma news,

Pfizer Q4FY23 profit up 3.1% at Rs 129.65 crore, revenue at Rs 572.64 crore; dividend declared

Pfizer’s revenue from operations was at Rs 572.64 crore, up 4.2 per cent from Rs 549.66 crore in the fourth…

May 15, 2023 18:25 IST

Pfizer bivalent vaccine reduces Covid-related death risk by 68 per cent in older people: Study

Bivalent mRNA vaccines, containing elements from both the original wild type COVID strain and an updated component from the omicron…

Updated: April 14, 2023 13:54 IST

Pfizer, Pfizer COVID drug, Paxlovid, healthcare news, pharma news, covid news,

Pfizer’s COVID-19 drug Paxlovid is less effective against viral infection

Scientists showed that drug-resistant variants have appeared multiple times independently in different parts of the world, with regional clusters providing…

March 30, 2023 14:43 IST

Pfizer, Pfizer India, appointments, India business, healthcare news,

Pfizer Limited appoints Meenakshi Nevatia as Managing Director and Additional Director

S. Sridhar the current India Country President will be stepping down as Managing Director and Member of Board close of…

February 9, 2023 19:49 IST

Pfizer, Pfizer drug portfolio, healthcare news, pharma news,

Pfizer to sell its full drug portfolio on not-for-profit basis in low-income countries

Reportedly, the programme is aimed at increasing access to innovative treatments in some of the world’s poorest countries.

January 18, 2023 13:33 IST

Pfizer, Pfizer India, patient assistance, health news, healthcare news,

Pfizer launches assistance app for patients in India

The confirmation of enrolment into the programme however is subject to the patient’s medical eligibility, and verification of required documents.

December 16, 2022 14:20 IST

Pfizer applies for FDA authorisation for omicron-retooled booster dose

According to the pharma major, this dose will come in the three-dose primary series for children 6 months through 4…

December 6, 2022 12:21 IST

Pfizer, Paxlovid, long COVID, coronavirus pandemic, health news, pharma news,

Pfizer’s Paxlovid to be tested for long COVID in United States

The trial will investigate a leading theory of the cause of long COVID, which holds that fragments of the virus…

October 28, 2022 12:44 IST

nse nifty, nifty50, stocks to buy, stock market

Nifty short-term trend positive, must hold above 17260 for considerable upmove; buy these two stocks for gains

The short-term trend of Nifty is range bound with positive bias. The market is now in an attempt to form…

October 13, 2022 08:37 IST

LifeCell, HaystackAnalytics, genetic testing, Tuberculosis, omega TB, health news, diagnostics news,

Pfizer India inks partnership with Father Muller Research to award fellowships to younger scientists

Moreover, the bespoke fellowships will be a form of recognition and will enable young clinicians who want to pursue medical…

September 26, 2022 15:10 IST

US cutting global donations of Pfizer/BioNTech COVID shots as demand slows

Pfizer said it agreed to reduce the number of doses it will deliver by year end to 600 million, down…

Updated: September 23, 2022 07:40 IST

Pharmaceuticals, paracetamol, indian pharmaceutical sector, health news, pharma news,

Haleon is not liable for potential liabilities over Zantac, says CEO

Haleon has repeatedly said that it never marketed Zantac in any form in the United States, either as Haleon or…

September 20, 2022 15:50 IST

Pfizer, Pfizer Inc, Influenza vaccines, mRNA vaccines, health news, pharma news,

Pfizer begins Phase III clinical trial of mRNA-based influenza vaccine

According to the company, the trial is being conducted to evaluate efficacy, safety, tolerability, and immunogenicity of the influenza vaccine.

September 14, 2022 17:05 IST

Neutraceuticals, pharmaceuticals, wellness supplements, drugs, health news, healthcare news,

Zenara Pharma launches first generic of Pfizer’s Paxlovid for COVID-19 in India

In December last year, this product’s approval in the United States was given by the USFDA and is indicated for…

September 9, 2022 15:11 IST

Pfizer’s RSV vaccine found effective and safe among older adults, study reveals

Pfizer’s shot is designed to target two strains of the respiratory virus. The company has so far enrolled about 37,000…

August 25, 2022 17:42 IST

Pfizer COVID pill showed no benefit in younger adults, says Study

The results from a 109,000-patient Israeli study are likely to renew questions about the U.S. government’s use of Paxlovid, which…

August 25, 2022 08:54 IST

Related News

150+ Best Happy Diwali 2025 Wishes: Professional, Personal & Bollywood-Style Unique Messages with Quotes and Images

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

B1/B2 visa rejected despite travel history: Applicant shares interview experience, says ‘officer spoke loudly and was…’

Diwali bonanza: 5 big central govt announcements for employees and pensioners this festive season

5 big central govt announcements for employees and pensioners ahead of this Diwali – Details here

120 + Happy Diwali Muhurat Trading 2025 wishes

120+ Happy Diwali wishes: Best messages for traders and investors to bring good luck and prosperity

Brokerages bet on retail, new energy to drive RIL’s growth

Market7 min ago

Analysts predict RIL to prioritize retail and fuel refining for growth, with focus on new energy and AI for future growth. Despite Q2FY26 earnings missing estimates, RIL’s performance is expected to boost investor confidence and prompt a re-rating. The company’s solar and giga factories are on track, and its retail business saw significant growth in fashion, grocery, and consumer electronics.

View all shorts